Instinct Bio Provides Operational Update on Indonesia Clinic
Consumer Goods
Business Update
Merger:
Jul 24, 2026
Industry:
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Instinct Bio Provides Operational Update on Indonesia Growth Platform and Product Initiatives
New York and Tokyo, USA and Japan - INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio") has provided an operational update regarding its GENREVER CLINIC platform in Indonesia and its product development collaborations with Invitrx Therapeutics, Inc. and PT Parva Candela.
... Read on — Members only
About INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Instinct Bio is a biotechnology company focused on regenerative medicine, longevity-related technologies and advanced therapeutic platforms. The Company is committed to developing innovative solutions intended to address unmet medical needs and support long-term human health outcomes.
For more information, please visit the Company’s website at https://instinct-biot.com/
More BIOT News
Consumer Goods
Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.
Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.